Interestingly enough same thing happened with OW$P, S-1 filing in June 2016 for $240,000 and within 3 months it went from .003 to $.18. Share structure was better, but drug pipeline wasn’t close to what we have here. Fact that lenders agreed to reduce number of common shares required in reserve is a good sign they want this to run, and run hard. I’ll be here till $.05 minimum.
News 
Market Data 
Discover 
